Science
Mechanism of Action
The 'Caprolactone' component, referring to Polycaprolactone (PCL), operates as a potent collagen stimulator. When introduced, PCL initiates a carefully orchestrated biological response through three distinct phases: inflammation, proliferation, and remodeling. This process involves the formation of new granulation tissue, followed by the early production of collagen type-III, ultimately leading to the sustained, long-term deposition of robust collagen type-I. Mechanically, the material creates a subtle tension that stretches fibroblasts, thereby activating these cells to increase their synthesis of both collagen and elastin.
Research
Clinical Evidence
Low confidenceN/A
Key findings
- 01 Polycaprolactone (PCL) fillers, when injected, exhibit a dual effect: an immediate volumetric correction from the carboxymethylcellulose (CMC) gel carrier and a sustained, long-term improvement attributed to stimulated collagen production. Injected PCL microspheres actively prompt fibroblasts to generate collagen type-I, contributing to the formation of a supportive 3D collagen scaffold within the tissue.
Transparency
Dusting Analysis
The provided research does not establish specific clinical efficacy percentages or dose ranges for POLYGLYCERYL-25/CAPROLACTONE in topical skincare applications. While its Polycaprolactone (PCL) component is well-documented for collagen stimulation in injectable forms, a 'dusting' threshold for topical cosmetic use cannot be determined based on the available data.
The Formula
Formulation
Stability
Polycaprolactone (PCL) nanoparticles exhibit accelerated degradation rates in highly acidic environments, particularly at pH 1.65 when maintained at 37°C. Refrigeration has been shown to significantly enhance the stability of PCL polymers, even under low pH conditions, preserving their integrity for several months. The polyglyceryl portion of this ingredient typically imparts hydrophilic characteristics, which contribute to its overall stability and functionality within a formulation.
Conflicts
- Highly acidic pH environments can catalyze the degradation of the Polycaprolactone (PCL) component.
Safety
Safety Profile
The Cosmetic Ingredient Review (CIR) Expert Panel has not specifically evaluated POLYGLYCERYL-25/CAPROLACTONE. However, its Polycaprolactone (PCL) component is FDA-approved as an implantable biomaterial in various medical contexts due to its cytocompatibility, biodegradability, and non-toxicity. While not directly reviewed, related ingredient families, such as 'Glycolactones' and 'Fatty Ester End-Capped Alkoxylates' (which include certain polyglyceryl esters), have undergone CIR assessment, with some found safe as used and others lacking sufficient data for a conclusion.
Your Skin
Skin Compatibility
Our Assessment
Verdict
While the Polycaprolactone component is a proven collagen stimulator in injectable forms, and the polyglyceryl component offers valuable formulation benefits, current research lacks specific data on the topical efficacy and optimal concentrations for POLYGLYCERYL-25/CAPROLACTONE in precision skincare formulations, leading to an 'insufficient-data' verdict for its full potential in this context.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources